Renovion, Inc.-preview

Renovion

Renovion, Inc.

Private

Chapel Hill, North CarolinaHealthcare & Life Scienceshttps://www.renovion.com/

Last Round

VC Round

Apr 3, 2023

Total Funding Raised

$9.15M

Momentum Score

75 /100

Company Overview

Renovion, Inc. is a clinical-stage pharmaceutical company that develops a nebulized therapy to restore mucus clearance and reduce inflammation in the lungs for patients with chronic inflammatory airway diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B2C

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

nebulized therapychronic lung diseaserespiratory therapyBronchiolitis Obliterans SyndromeBOSorphan drugnon-cystic fibrosis bronchiectasisNCFBElung transplant therapymucus clearanceinhalation therapyclinical stage pharmabiopharmaceutical companychronic bronchitisCOPDFDA Fast Trackcystic fibrosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Renovion, Inc. Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Renovion, Inc. Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Apr 3, 2023
Grant	Nov 18, 2021
Series A	Jun 18, 2020
Seed	Jan 6, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Dan Copeland

CEO

Executive Team

Renovion, Inc. Investors

Notable investors and investment history

Investor	Rounds
Onbelay Capital	Seed
KickStart Venture Services	Grant
First Flight Venture Center	Seed
COPD Foundation	VC Round
Leerink Partners	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 18, 2026
Monthly visitors increased 48% MoM.
Jan 6, 2026
Monthly visitors grew 100% MoM, reaching 957.

View all signals

Renovion, Inc. Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Renovion, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Renovion, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersChapel Hill, North Carolina

Employee Range6

Year Founded2013

Last FundingApr 3, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.